From: Preliminary result of carbon-ion radiotherapy using the spot scanning method for prostate cancer
 | Univariate |  |  | Multivariate |  |  |
---|---|---|---|---|---|---|
 | OR | (95% CI) | p-value | OR | (95% CI) | p-value |
Late grade 2 GU toxicity (n = 17) | ||||||
 Age | 1.00 | (0.93–1.07) | 0.986 | 1.01 | (0.93–1.09) | 0.863 |
 Risk group | 0.68 | (0.30–1.56) | 0.363 | 1.31 | (0.27–6.45) | 0.741 |
 ADT duration | 0.98 | (0.93–1.02) | 0.337 | 0.96 | (0.88–1.05) | 0.407 |
 DM | 3.32 | (0.99–11.15) | 0.052 | 2.94 | (0.80–10.82) | 0.105 |
 Anticoagulants | 0.31 | (0.04–2.38) | 0.258 | 0.26 | (0.03–2.28) | 0.227 |
 BPH | 1.72 | (0.36–8.14) | 0.496 | NA | – | – |
 TURP | 15.60 | (2.05–118.58) | 0.008 | NA | – | – |
Late grade 2 GI toxicity (n = 3) | ||||||
 Age | 1.07 | (0.90–1.29) | 0.438 | 1.09 | (0.0.88–1.35) | 0.422 |
 Risk group | NA | – | – | NA | – | – |
 ADT duration | 1.02 | (0.97–1.08) | 0.403 | 0.98 | (0.82–1.18) | 0.850 |
 DM | 4.93 | (0.43–56.53) | 0.199 | 6.27 | (0.42–94.06) | 0.184 |
 Anticoagulants | 2.63 | (0.23–29.64) | 0.435 | 1.15 | (0.08–16.27) | 0.920 |
 BPH | NA | – | – | NA | – | – |
 TURP | NA | – | – | NA | – | – |